In a remarkable discovery with transformative implications for humans, researchers have discovered and detailed the process by which a protein serves as the switch for releasing cancer cells throughout a body from an original cancer site. The protein called disabled-2 (Dab2) is critical to many of the most common and deadly forms of cancer, including breast and colon cancer.
The scientists have added details in the understanding of the process called epithelial-mesenchymal transdifferientiation (EMT). Dr. Ge Jin, who has joint appointments at the Case Western Reserve University School of Dental Medicine and the Lerner Research Institute at the Cleveland Clinic, discovered that when the researchers knocked out Dab2, EMT was not triggered.
That has obviously amazing potentialities for cancer treatments.
For the full story, click here.